<DOC>
	<DOC>NCT02311595</DOC>
	<brief_summary>The purpose of this study is to determine if reduced port totally laparoscopic distal gastrectomy with complete D2 lymph node dissection for gastric cancer is safe and oncological feasible. 67 patients with gastric cancer with preoperative staging from T1 to T3 will undergo reduced port totally laparoscopic distal gastrectomy. The primary end point of this study is to measure compliance rate with pathology report and compare with previous compliance rate data.</brief_summary>
	<brief_title>A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>histologically confirmed adenocarcinoma of the stomach Eastern Cooperative Oncology Group Eastern Cooperative Oncology Group performance status 01, signed informed consent location of the primary tumor in the antrum, angle and lower body no evidence of distant metastasis or invasion to adjacent organs or serosal infiltration metastatic disease previous history of malignancy in any organ any comorbidity obviating major surgery</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>laparoscope</keyword>
</DOC>